Allmed is the only global manufacturer that achieves integrated, large-scaled, and intelligent production in the industry across medical dressings, infection control products, and medical non-woven products. After nearly thirty years of development, Allmed has accumulated extensive industry experience and production technology. Through continuous innovation and effective integration, Allmed has established systematic production lines that are industry-specific and meet international advanced standards, forming a complete industry chain that covers all production stages, including raw materials, semi-finished products, deep processing, packaging, sterilization, and testing.

While introducing advanced foreign production equipment, Allmed continuously invests in the independent research and development of specialized equipment and has obtained a number of patents. Allmed persistently upgrade our equipment and processes, further enhancing the automation, intelligence, and integration of each production stage in the industry chain. The full industry chain integration production strategy enables us to maintain significant competitive advantages in product quality control, cost reduction, and increased automation levels.

Since its establishment, Allmed has consistently prioritized product quality and brand reputation, adopted international industry standards to implement product quality control, and established a comprehensive quality control system and procedures. Allmed has formed a whole-process quality management system from the selection of raw materials to production and inspection, not only selecting high-standard raw materials, but also equipped with EO sterilization production lines and steam sterilization production lines, combined with automated equipment to control the production process, and specialized management of key processes, to ensure that products comply with the quality standards and requirements from the raw material inputs to the final products.

Allmed’s quality management system follows the ISO 13485 standards and complies with the Good Manufacturing Practice for Medical Devices and the relevant appendices for sterile medical devices. We also refer to the requirements of the U.S. FDA QSR 820 regulation, the European Union's MDR medical device directive and Japan's Pharmaceutical Affairs Law to ensure that we meet the regulatory requirements of different domestic and international markets. Allmed has been successfully registered in many countries and obtained a number of international certifications, including FDA factory registration in the United States, Foreign Manufacturer Recognition Certificate from the Ministry of Health and Welfare in Japan, as well as medical device product registration from the German medical device authority, and has passed the CE marking for the EU products by TUV in South Germany.

Allmed has always insisted on R&D and innovation as the core driving force for development, continuously increasing R&D investment, optimizing process level, innovating production equipment and technology, and at the same time cultivating and attracting innovative talents, which has established a relatively comprehensive R&D system and consolidated its competitive position in the industry.

As a high-tech enterprise focusing on medical dressings, Allmed has been authorized with a number of invention patents, accumulated solid technical achievements and maintained our leading position in the medical dressing industry. In addition to continuous investment in product innovation, equipment upgrading and transformation, Allmed also has increased investment in automation, informationisation and intelligent management, and successfully developed Allmed Medical WMS Management System, Allmed Barcode Management System, and Allmed ETO Management System, Allmed ETO Sterilization Process Visualization Management Software, and other software, for which corresponding copyrights have been obtained.

As of 31 December 2024, Allmed has obtained 51 patents for invention, 292 patents for utility models, 77 patents for designs and 21 software copyrights.

Adhering to the core values of ‘integrity, focus and professionalism’, Allmed continues to provide customers with quality products and services. Allmed’s products have been exported to more than 70 countries and regions in six continents, and main markets include the United States, Canada, Germany, Japan and other countries. The customers are mainly internationally renowned brand names with whom we have established long-term and stable cooperative relationships, forming an outstanding customer resource advantage. Allmed’s market share in several key markets has continued to increase, and has ranked first in China's medical dressing export industry for 17 consecutive years.

With a long-term focus on healthcare, Allmed is committed to meeting our customers' needs in terms of product quality, capacity assurance, delivery time and customer service. Allmed provides our customers with high quality pre-sales and after-sales services and have established solid customer relationships. Currently, the main customers include Medline, Dukal, Hartmann, Lohmann & Rauscher, Medicom, Johnson & Johnson, McKesson and other internationally renowned companies. In the long-term strategic cooperation with these global leaders, Allmed has grown together with customers, received consistent recognition from them, and increased customer stickiness, thus achieving sustainable development and maintaining core competitiveness.

Allmed’s management team has been dedicating to the research and development, production and sales of medical dressings for a long time, with an average of over 25 years in the industry, and has accumulated rich management experience. After years of experience accumulation and talent cultivation, Allmed has trained a group of professionals covering the fields of sales, marketing, R&D, supply chain and whole industry chain manufacturing, which has laid a solid foundation for the sustainable development of the Company.